2025 BEGINS WITH DOWNTURN IN THE NEW MOTORCYCLE MARKET, NMDA WELCOMES POTENTIAL REVIEW OF TRAINING, TESTING, AND LICENSING REGULATIONS

“After showing signs of growth in the new motorcycle market towards the end of 2024, January saw a decline of -30.5% in total registrations, with many motorcycle categories experiencing a downturn” says Symon Cook, Head of National Motorcycle Dealers Association (NMDA), commenting on the latest MCIA figures.

In January, there was a -30.5% decrease in total registrations, from 6,043 to 4,201 units. Total motorcycle sales declined by -30.4% from 5,656 to 3,936 units, whilst moped registrations also dropped by -35.3% to 231 units.

The majority of motorcycle categories experienced declines during the month, ‘Modern Classic’ saw a decrease of -13.3% for the month to 547 units. ‘Adventure’ dropped by -35.0% to 734 units. ‘Touring’ grew by 48.8% from 80 to 119 units.

Electric motorcycles experienced a decline, with registrations dropping from 253 to 172 units, a decrease of -32.0%.

In terms of the different ICE capacities, all experienced falls, with the 126-500cc category declining by -31.2% as did the larger engines, with 751-1000cc dropping by -5.9%.

Honda was the best-selling brand in January with 851 units sold. Yamaha followed with 443 units, BMW came in third with 412 units, and Royal Enfield completed the top ten with 76 models sold.

Symon Cook concluded: “January is traditionally a slower month for two-wheeler registrations with the colder weather often having an impact.

“2024 was a challenging year for the new motorcycle market with dealers having to face a perfect storm of challenges. NMDA members have demonstrated resilience and adaptability in the face of challenges.

“In 2025, it is essential for the Government to provide greater clarity for the sector. Last month, the NMDA welcomed news that the Department for Transport is considering a review of the current training, testing and licensing regime.

“As a key part of the automotive industry, the sector remains a priority, and NMDA will continue its lobbying efforts throughout the year.”